Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujie Cui

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Cell Death Discovery|May 11, 2023
GSDME-dependent pyroptosis signaling pathway in diabetic nephropathyShengyu Li, Lifeng Feng, Guangru Li, et al.
Cancers|July 9, 2022
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast CancerJin Sun Lee, Susan E Yost, Sierra Min Li, et al.
The Oncologist|April 6, 2023
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast CancerYuan Yuan, Susan E Yost, Yujie Cui, et al.
Nature|March 23, 2012
Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancyYujie Cui, Wei Wang, Ningzheng Dong, et al.
Cancer|December 14, 2022
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancerSayeh M Lavasani, George Somlo, Susan E Yost, et al.
Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancerColt A Egelston, Weihua Guo, Susan E Yost, et al.
Annals of Clinical and Translational Neurology|March 17, 2026
Paramagnetic Rim Lesions Are Associated With Trans-Synaptic Degeneration of the Visual Pathway in Multiple SclerosisAbdul Jaber Tayem, Angel Liu, Sargis Manukyan, et al.
JAMA Oncology|August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical TrialSumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
Science Translational Medicine|July 17, 2020
High-loading Gα<sub>13</sub>-binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia/reperfusion injuryAiming Pang, Ni Cheng, Yujie Cui, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Cell Death Discovery|May 11, 2023
GSDME-dependent pyroptosis signaling pathway in diabetic nephropathyShengyu Li, Lifeng Feng, Guangru Li, et al.
Cancers|July 9, 2022
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast CancerJin Sun Lee, Susan E Yost, Sierra Min Li, et al.
The Oncologist|April 6, 2023
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast CancerYuan Yuan, Susan E Yost, Yujie Cui, et al.
Nature|March 23, 2012
Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancyYujie Cui, Wei Wang, Ningzheng Dong, et al.
Cancer|December 14, 2022
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancerSayeh M Lavasani, George Somlo, Susan E Yost, et al.
Cancers|September 9, 2022
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast CancerXuan Ge, Susan E Yost, Jin Sun Lee, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancerColt A Egelston, Weihua Guo, Susan E Yost, et al.
Annals of Clinical and Translational Neurology|March 17, 2026
Paramagnetic Rim Lesions Are Associated With Trans-Synaptic Degeneration of the Visual Pathway in Multiple SclerosisAbdul Jaber Tayem, Angel Liu, Sargis Manukyan, et al.
JAMA Oncology|August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical TrialSumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
Science Translational Medicine|July 17, 2020
High-loading Gα<sub>13</sub>-binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia/reperfusion injuryAiming Pang, Ni Cheng, Yujie Cui, et al.
Pageof 13